Precommercializing a Method For Inducing Muscle Fiber Formation For Industrial Meat Production
This project aims to enhance in vitro muscle formation for cultured meat production by leveraging a novel signaling cascade to improve efficiency and commercialization potential.
Projectdetails
Introduction
The global population is expected to reach the 9 billion mark by 2050, which will cause an increase of 70% in the global demand for food. However, if the global trends of meat and animal products consumption continue at the current rate, the global mean temperature will rise by over 2°C despite the emissions of non-agricultural sectors being drastically decreased.
Need for Efficient Protein Production
Therefore, a growing need exists to develop more efficient protein production options. During embryonic muscle development, myoblasts proliferate and undergo differentiation, a multistep process which requires:
- Cell cycle withdrawal
- Initiation of a muscle-specific gene transcriptional program
- Differentiation into fusion competent myoblasts
- Ultimately, cell-to-cell fusion to form nascent multinucleated myotubes that mature to form contractile muscle fibers
Novel Signaling Cascade
We have identified a novel signaling cascade that is easily controlled by a small molecule inhibitor, leading to faster and more robust in vitro muscle formation than can be achieved with the conventional differentiation medium. This occurs through the induction of synchronous differentiation and ultimately enhanced cell-to-cell fusion of the muscle progenitor cells.
Implications for Cultured Meat Industry
The discovery of a signaling cascade which enhances myoblast fusion draws parallels to the needs of the newly established and ever-growing field of cultured meat, which builds upon the techniques used for decades in the in vitro study of myogenesis. The cultured meat industry is actively seeking ways to increase production efficiency in order to reach price parity with the current meat industry.
Project Goals
Therefore, taking advantage of processes that can speed up and enhance the efficiency of myoblast fusion would facilitate this achievement. The goals of the PoC project are to:
- Improve the maturity of our idea by bringing it to higher TRLs (Technology Readiness Levels)
- Implement a pre-commercial prototype of the proposed product
- Explore its commercialization potential
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-4-2022 |
Einddatum | 30-9-2023 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- WEIZMANN INSTITUTE OF SCIENCEpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Decellularised Extracellular Carpets for the Innovative Production of Human Engineered ReplicatesThis project aims to accelerate the development of cell-derived products using macromolecular crowding, enhancing European biotech competitiveness and creating new jobs and markets. | ERC Proof of... | € 150.000 | 2024 | Details |
An automated platform for the large-scale production of miniaturized neuromuscular organoidsThe project aims to automate and scale the production of complex neuromuscular organoids for high-throughput drug screening to advance therapies for neuromuscular diseases. | ERC Proof of... | € 150.000 | 2023 | Details |
Human skeletal muscle platform for disease modelling and high-throughput drug screeningDeveloping a high-throughput in vitro platform with biomimetic skeletal muscle analogues to model neuromuscular disorders for effective drug screening and therapy validation. | ERC Proof of... | € 150.000 | 2023 | Details |
Translating a new metabolic engineering strategy to industrial biotech applicationsThe TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production. | ERC Proof of... | € 150.000 | 2023 | Details |
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticlesThe NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release. | ERC Proof of... | € 150.000 | 2024 | Details |
Decellularised Extracellular Carpets for the Innovative Production of Human Engineered Replicates
This project aims to accelerate the development of cell-derived products using macromolecular crowding, enhancing European biotech competitiveness and creating new jobs and markets.
An automated platform for the large-scale production of miniaturized neuromuscular organoids
The project aims to automate and scale the production of complex neuromuscular organoids for high-throughput drug screening to advance therapies for neuromuscular diseases.
Human skeletal muscle platform for disease modelling and high-throughput drug screening
Developing a high-throughput in vitro platform with biomimetic skeletal muscle analogues to model neuromuscular disorders for effective drug screening and therapy validation.
Translating a new metabolic engineering strategy to industrial biotech applications
The TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production.
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat ApplicationsProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients. | EIC Transition | € 2.432.030 | 2024 | Details |
Haalbaarheidsstudie voor een groeifactorproductiebedrijfHet project richt zich op het verlagen van de kosten van groeifactoren voor kweekvleesproductie door deze op grotere schaal te produceren, ter ondersteuning van de eiwittransitie. | Mkb-innovati... | € 20.000 | 2022 | Details |
Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analoguesThe MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026. | EIC Accelerator | € 2.441.250 | 2024 | Details |
Productie van nieuwe vleesvervangers op basis van microbieel eiwitDalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid. | Mkb-innovati... | € 113.663 | 2018 | Details |
Kweekvlees op boerderijschaalDit project valideert het ontwerp en verdienmodel van lokaal geproduceerde kweekvlees op boerderijschaal voor duurzame voedselproductie. | 1.1 - Het ve... | € 238.956 | 2022 | Details |
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat Applications
ProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients.
Haalbaarheidsstudie voor een groeifactorproductiebedrijf
Het project richt zich op het verlagen van de kosten van groeifactoren voor kweekvleesproductie door deze op grotere schaal te produceren, ter ondersteuning van de eiwittransitie.
Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues
The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.
Productie van nieuwe vleesvervangers op basis van microbieel eiwit
Dalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid.
Kweekvlees op boerderijschaal
Dit project valideert het ontwerp en verdienmodel van lokaal geproduceerde kweekvlees op boerderijschaal voor duurzame voedselproductie.